Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 13 of 93 Results 121 to 130 of 923
Identifying opportunities for earlier diagnosis of high-risk COPD patients in Australia: an observational study
TSANZSRS 2024Contributions to Conferences: AbstractsHandling Class Imbalance in Machine Learning-based Prediction Models: A Case Study in Asthma Management
Chapters in Books, Reports and Conference Proceedings: Conference Proceedings- [ONLINE] DOI: https://doi.org/10.1109/EMBC40787.2023.10340751
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/9cca628b-247b-4cd1-b4b6-5936b3771fad/download
- [ONLINE] EMBC 2023
Biomarkers expression, treatment and disease burden in a cohort of Italian patients affected by severe asthma: a sub analysis of the ISAR EVEREST study
EAACI Congress 2023, pp. TP-A25Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/all.15925
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/5488e535-a75c-4c2c-b24a-5891c481ec0b/download
Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study
EAACI Congress 2023, pp. 415Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/all.15925
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/3dbec71f-5841-482c-9e80-7fe2fc2fb2b2/download
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
International journal of chronic obstructive pulmonary disease , vol. 2023, no. 18, pp. 2565—2580Contributions to Journals: ArticlesS117 Clinical remission in patients with severe eosinophilic asthma: an analysis of SIROCCO and CALIMA trial data
Thorax, vol. 78, no. Suppl 4, pp. A84-A84Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/thorax-2023-BTSabstracts.123
Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study
Advances in Therapy, vol. 40, no. 11, pp. 4836-4856Contributions to Journals: ArticlesPotential value of quality improvement in difficult-to-treat and severe asthma in Australia; an opportunity analysis
APSR 2023, pp. 342-343Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/resp.14617
Clinical remission following biologic initiation in severe asthma: results of the International Severe Asthma Registry (ISAR)
ERS 2023 International Congress, PA1891Contributions to Journals: AbstractsIdentifying opportunities for earlier diagnosis of high-risk COPD patients in Australia: an observational study
ERS 2023 International Congress, PA3635Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2023.PA3635